🇺🇸 FDA
Pipeline program

Lidocaine IV

SMC 2022-10-021-002

Unknown small_molecule completed

Quick answer

Lidocaine IV for Colorectal Cancer is a Unknown program (small_molecule) at Samsung Bioepis NL B.V. with 1 ClinicalTrials.gov record(s).

Program details

Company
Samsung Bioepis NL B.V.
Indication
Colorectal Cancer
Phase
Unknown
Modality
small_molecule
Status
completed

Clinical trials